Alzheimer’s Disease, since first identified in 1902 by Dr
Alois Alheimer, was not then understood. It is not understood much more today.
Generically it is a name given to common symptoms of brain damage or brain
dysfunction that starts out gradually and progresses to the point that it takes
the mind then the body and then the person afflicted with it. When it is done
wreaking its vengeance the person dies.
It falls under the class known as Dementia. There are other
kinds of Dementia, the most numerous diagnoses is of those said to have AD. The
process is nonetheless the same. The brain and the body go than goes the person
with it. In the later stages little can be done for the person with it other
than trying to make that person comfortable. In the earlier stages much can be
done to secure the person afflicted with a good quality of life, and keep
her/him functional and out of institutionalization as long as possible. This
adds to quality of life and saves society the cost of care which is intolerably
high.
The history of AD treatment and diagnosis is checkered.
Until the late ‘60’s and early ‘70’s little was known or discussed about it. It
was an old people’s disease, contracted only by the person old enough to have
it, and then it was considered more likely senility, a simple aging breakdown
of the brain’s ability in cognition. No great attention was given it, if you
were “lucky” enough to live long enough it is something that came with that geography.
In 1970 the numbers grew enough to create concern in the professional
community. As related by a charter director of the National Institute of Health
(NIH) in an address of his I attended he stated that it was around this time
the government started to fund the NIH with the directive that they deal with
AD. Getting into the field the NIH found research deficient as to
identification of the mechanics of AD and/or how to deal with it from a care
stand point. They were particularly concerned about the total absence of
knowledge about what happened in the body to bring the apparent brain cell
damage about, and how to arrest its progress in doing that.
He explained that the NIH did not have the mandate to do research.
Research of AD was horribly deficient. They could not expend their funds to do
research. Therefore, in conjunction with another group trying to form a group
to deal with AD, they formed the Alzheimer’s Association. They gave it the
direction to become involved in raising money to fund research on AD.
Very quickly the funding activity narrowed to that of
raising money to find the cure. This is why they were formed; (according to the
rep from NIH) this is what they were charged to do. They have been doing that
ever since.
Noteworthy portions of the article said the following:
Although intensely investigated over the last three decades
using cutting-edge technologies, the “pathogenic cause” of Alzheimer’s disease
has not been found. While many research “breakthroughs” have been claimed and
high-profile drugs trials carried out, why does the promised “cure” still seem
to elude scientists?
In an effort to address this question(the author’s) undertook an independent and systematic analysis of the
underlying research assumptions against the established scientific principles.
This analysis led them to hypothesize that perhaps the main problem is the research community’s perception of the disease.
…the authors suggest
that when the National Institutes of Health separated out dementia from other
senile conditions and redefined it as a distinct and “curable” disease —
Alzheimer’s – in the 1970s, it opened a Pandora’s box and may have misdirected
research for decades. It triggered the search for pathogenic factors and
cures, and disregarded the role of demographic change and its diverse end
results in the elderly.
The authors argue that senile disorders – diseases occurring
after age 60 and eventually affecting the majority of the elderly, such as
tooth, hearing or memory loss – are caused by aging, thus differ fundamentally
from distinct diseases by origin, study paradigm and intervention strategy…
… “Lifestyles and other risk factors are the key.
So we think that senile dementia may be explained by ‘advanced aging plus
risk factors.’ This model points to a new direction for prevention.
This means we must support the elderly in healthy lifestyles. And we
should develop medications to extend the lifespan of old neurons, rather
than looking for ways to inhibit far-fetched ‘pathogenic’ factors.”
…Since they have not taken into account the fundamental
roles of aging and risk factors, it is clear that these theories, though highly
appealing to the public and researchers alike, are of little relevance to the
scientific nature of senile dementia.”
“The two overwhelming concepts, senile dementia as a
distinct disease and the Ca2+ overload hypothesis, have effectively
blocked any meaningful progress in senile dementia research, and have inhibited
the self-correcting mechanism of science,” concludes Dr. Chen. “An
independent scrutiny on the field may be helpful.”
The agenda of the Alz.Assoc to raise money to fund research
is a wonderful mandate to follow.
Nevertheless it should be stated by
them openly instead of sensationalizing the disease as they do in an effort to
raise funds. Each of the state satellites of Alz.Assoc is charged with raising
money, was required to pay over 40% of what they raise which has now been
increased to 60% I have read . (See:
The
Local Versus National Alzheimer's Presence by clicking on it and go to my
archive where I have an article discussing this by a person from Wisconsin)
Not disclosing the cut and the
singular agenda raising funds is tantamount to fraud. Worse than that it is
exploitation of those of us with the disease to work for the funds and wave our
limitations before the public.
Never do we hear from the Alz.Assoc “Let’s help out the
folks afflicted by the disease remain functional.” The absence of such comments
and the further absence of meaningful programs for early stage validate this.
There is no attempt to attack the cost of institutionalization or find economy
in care. They are just too busy with fund raising activities.
Some local chapters becoming aware of this discrepancy in
activity have been withdrawing from the Alz.Assoc and refusing further funding
to them. This seems be heard because all of a sudden we are seeing activity
starting to fill this gap.
As recently as January 27th of this year Harry
Johns President and CEO of the Alzheimer's Association made the
following comment as a news release:
Alzheimer's
is a tragic epidemic that has no survivors. Not a single one,
As part of that release he went on to say, almost quoting
Alois Alzheimer, there is nothing we can do for them but keep them safe and
make them comfortable when finally we must institutionalize them. Based on this
supported by a publication of the Assoc. that stressed the numbers and the
coming epidemic level that AD will reach, he stated only option to stave of the
negative affect is raise more money to find the cure.
In my career as a trial lawyer I have heretofore stated I
learned a lot about medicine. One case I handled in upper New York State was that
of a child with a pre-natal developmental disorder. My friend the doctor who
worked with me put me in contact with one of the top experts in the country at
Harvard. His field was Pre-Natal Developmental Disorders. I retained him, sent
him all the information he needed and asked his advice and direction. I wanted
to know what I was dealing with.
He told me there were as many different pre-natal
development disorders as there we children born with them. Each one was
different than the others. The medical practice dealing with them tries to
categorize them under similar symptoms. He used Down’s syndrome as an example.
Everyone believes this is one illness. It is not, each one is different. There
are similarities like so-called Mongoloid eyes, short lifespan, limited
cognitive ability etc. But each one is different from all the others. These
disorders do not have a singular source of cause and singular way of treatment.
I remembered this when I encountered AD. It seemed to me AD
was as generic as Dementia. The fact the Dementia included AD, this made it
larger in number than AD but little else made each person having it different
from all the others. It struck me that it each case has no common cause. Some
of the causes are genetic predisposition, early onset, later onset, different limitation
and different courses of the disease.
How could the professionals hope to find one medication that
would get at the core of the cause of the disease in order to put an end to it?
This leads me to the next topic I will deal with in my next
post. Well-meaning as all of the professionals are, particularly the fund
raisers, something fundamental seems awry. I have believed a silent agenda
exists that is the reason for the singular approach of the Alz.Assoc. I am
deeply troubled by the sense of being used as one afflicted with this disease.
We are listened to appointed to serve in an advisory way on a variety of
boards, but we are not heard. We are patronized, patted on the head and made
available to the media to give personal testimonials in the nature of “A Day in
the Life of One Afflicted by Alzheimer’s”